CV Sciences, Inc.
CVSI
$0.03
$0.00196.76%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.88M | 3.87M | 3.95M | 4.00M | 3.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.88M | 3.87M | 3.95M | 4.00M | 3.80M |
| Cost of Revenue | 2.21M | 2.09M | 2.09M | 2.15M | 2.06M |
| Gross Profit | 1.68M | 1.78M | 1.86M | 1.85M | 1.74M |
| SG&A Expenses | 2.06M | 2.01M | 1.92M | 2.44M | 2.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | 0.00 |
| Total Operating Expenses | 4.29M | 4.13M | 4.04M | 4.62M | 4.44M |
| Operating Income | -403.00K | -261.00K | -83.00K | -620.00K | -638.00K |
| Income Before Tax | -740.00K | -456.00K | -584.00K | -622.00K | -878.00K |
| Income Tax Expenses | -14.00K | -- | -- | 6.00K | -9.00K |
| Earnings from Continuing Operations | -726.00K | -456.00K | -584.00K | -628.00K | -869.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -726.00K | -456.00K | -584.00K | -628.00K | -869.00K |
| EBIT | -403.00K | -261.00K | -83.00K | -620.00K | -638.00K |
| EBITDA | -289.00K | -180.00K | -7.00K | -557.00K | -579.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 184.33M | 182.26M | 172.42M | 163.08M | 156.48M |
| Average Diluted Shares Outstanding | 184.33M | 182.26M | 172.42M | 163.08M | 156.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |